Rheumatic fever diagnosis, management, and secondary prevention: A New Zealand guideline

New Zealand Medical Journal

Volumn 121, Issue 1271, 2008, Pages 59-69

  Atatoa Carr, Polly ^a   Lennon, Diana ^b   Wilson, Nigel ^c,d   Arroll, Bruce ^e   Farrell, Elizabeth ^e   Jarman, Jonathan ^e   Kerdemelidis, Melissa ^e   Mason, Henare ^e   Morreau, Johan ^e   Nicholson, Ross ^e   Peat, Briar ^e   Spinetto, Heather ^e   Voss, Lesley ^e  

^a WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c New Zealand Guidelines Group   (New Zealand)

^d STARSHIP CHILDREN S HOSPITAL   (New Zealand)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BENZATHINE PENICILLIN; CARBAMAZEPINE; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLIN G; PENICILLIN V; SALICYLIC ACID DERIVATIVE; VALPROIC ACID;

ARTICLE; CARDITIS; CHOREA; CLINICAL FEATURE; DENTAL CARE; DRUG TREATMENT FAILURE; ECHOCARDIOGRAPHY; HUMAN; INCIDENCE; NEW ZEALAND; NONHUMAN; PATIENT COMPLIANCE; PHARYNGITIS; POLYARTHRITIS; PRACTICE GUIDELINE; PREVALENCE; RECOMMENDED DRUG DOSE; RHEUMATIC FEVER; RHEUMATIC HEART DISEASE; SECONDARY PREVENTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; SUBCUTANEOUS NODULE; THROAT CULTURE; HOSPITALIZATION; REVIEW;

ECHOCARDIOGRAPHY; HUMANS; NEW ZEALAND; PENICILLIN G, BENZATHINE; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RHEUMATIC HEART DISEASE; SEVERITY OF ILLNESS INDEX;

EID: 42949086503     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. New Zealand Rheumatic Fever Writing Group. New Zealand Guidelines for Rheumatic Fever. 1. Diagnosis, Management and Secondary Prevention. National Heart Foundation of New Zealand and the Cardiac Society of Australia and New Zealand. 2006. http://www.nhf.org.nz/ index.asp?pageID=2145846025
2. Carapetis JR, Brown A, Wilson NJ, et al. An Australian guideline for rheumatic fever and rheumatic heart disease: An abridged outline. Med J Aust. 2007;186:581-6.
3. Lennon D. Acute Rheumatic Fever. In: Feigin R and Cherry J (Eds), Textbook of Pediatric Infectious Diseases, 5th ed. Philadelphia: WB Saunders; 2004:413-26.
4. Stanhope J. New Zealand trends in rheumatic fever 1885-1971. N Z Med J. 1975;82:297-9.
5. Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the Top End of Australia's Northern Territory. Med J Aust. 1996;164:146-9.
6. Neutze J. Rheumatic fever and rheumatic heart disease in the Western Pacific region. N Z Med J. 1988;101:404-6.
7. Carapetis JR. A review of WHO activities. In: The Burden of and the Evidence for Strategies to Control Group A Streptococcal Diseases: Part 3: The Current Evidence for the Burden of Group A Streptococcal Diseases. Geneva: World Health Organization; 2004:1-49.
8. Christmas B. Management of rheumatic fever: A review. N Z Med J. 1984;97:598-600.
9. Neutze J, Clarkson P. Rheumatic fever: An unsolved problem in New Zealand. N Z Med J. 1984;97:591-3.
10. Thornley C, McNicholas A, Baker M, Lennon D. Rheumatic fever registers in New Zealand. Public Health Report. 2001;8:41-4.
11. Frankish JD, Stanhope JM, Martin DR et al. Rheumatic fever and streptococci: The Wairoa College study. N Z Med J. 1978:87:33-8.
12. Newman JE, Lennon DR, Wong-Toi W. Patients with rheumatic fever recurrences. N Z Med J. 1984;97:678-80.
13. Spinetto H. Recurrences of Rheumatic Fever in Auckland, 1993-1999. Thesis for Master of Health Science: University of Auckland; 2003.
14. Stollerman GH. Rheumatic fever in the 21st century. Clinical Infectious Disease. 2001;33:806-14.
15. McNicholas A, Lennon D, Crampton P, Howden-Chapman P. Overcrowding and infectious diseases - when will we learn the lessons of our past? N Z Med J. 2000;113:453-4.
16. World Health Organisation Cardiovascular Diseases Unit and Principal Investigators. WHO programme for the prevention of rheumatic fever/ rheumatic heart disease in 16 developing countries: Report from phase I (1986-90). Bull World Health Organ. 1992;70:213-8.
17. North DA, Heynes RA, Lennon DR, et al. Analysis of costs of acute rheumatic fever and rheumatic head disease in Auckland. NZ Med J. 1993; 106:400-3.
18. Jones TD. Diagnosis of rheumatic fever. JAMA. 1944; 126:481-4.
19. Special Writing Group of the Committee on Rheumatic Fever and Kawasaki Disease of the Council on Cardiovascular Disease in the young of the American Heart Association, Guidelines for the Diagnosis of Rheumatic Fever. Jones criteria 1992 update. JAMA. 1992;268:2069-73.
20. Wilson NJ, Neutze JM. Echocardiographic diagnosis of subclinical carditis in acute rheumatic fever. Int J Cardiol 1995:50:1-6
21. World Health Organisation. Rheumatic fever and rheumatic heart disease: Report of a WHO expert consultation. Geneva: World Health Organization Tech Rep Ser. 2004:923. http://www.who.int/cardiovasculardiseases/ resources/trs923/en/
22. Rutstein DD, Bauer W, Dorfman A, et al. Report of the committee on standards and criteria for programmes of care of the council of rheumatic fever and congenital heart disease of American Heart Association. Jones criteria (modified) for guidance in the diagnosis of rheumatic fever. Circulation. 1956;13: 617-20.
23. Abernethy M, Bass N, Sharpe N, et al. Doppler echocardiography and the early diagnosis of acute rheumatic fever. Aust N Z J Med. 1994;24:530-5.
24. Voss LM, Wilson NJ, Neutze JM, et al. Intravenous immunoglobulin in acute rheumatic fever: A randomized control trial. Circulation. 2001;103:401-6.
25. Swedo SE, Leonard HL, Mittleman BB, et al. Identification of children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections by a marker associated with rheumatic fever. Am J Psychiatry. 1997;154:110-2.
26. Kurlan R, Kaplan EL. The pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) etiology for tics and obsessive-compulsive symptoms: Hypothesis or entity? Practical considerations for the clinician. Pediatrics. 2004; 113:883-6.
27. De Cunto CL, Giannini EH, Fink CW, et al. Prognosis of children with poststreptococcal reactive arthritis. Pediatr Infect Dis J. 1988;7:683-6.
28. Shulman ST, Ayoub EM. Poststreptococcal reactive arthritis. Curr Opin Rheumatol. 2002;5:562-5.
29. Lennon D, Stewart J, Farrell E, et al. Re-evaluation of a school-based primary prevention of acute rheumatic fever (ARF) randomised controlled trial (RCT): Poised for action. The XVIth Lancefield International Symposium on Streptococci and Streptococcal Diseases: Abstract. September 2005
30. Shet A, Kaplan EL. Clinical use and interpretation of group A streptococcal antibody tests: A practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J. 2002;21: 420-30.
31. Albert DA, Harel L, Karrison T. The treatment of rheumatic carditis: A review and meta-analysis. Medicine (Baltimore). 1995;74:1-12.
32. Cilliers AM, Manyemba J, Saloojee H: Anti-inflammatory treatment for carditis in acute rheumatic fever. Cochrane Database Syst Rev. 2003;CD003176.
33. Sanyal SK, Berry AM, Duggal S, et al. Sequelae of the initial attack of acute rheumatic fever in children from North India. A prospective 5-year follow-up study. Circulation. 1982;65:375-9.
34. Feinstein AR, Stern EK, Spagmuolo M. The prognosis of acute rheumatic fever. Am Heart J. 1964; 68:817-34.
35. Majeed HA, Batnager S, Yousof AM, et al. Acute rheumatic fever and the evolution of rheumatic heart disease: A prospective 12 year follow-up report. J Clin Epidemiol. 1992;8:871-5.
36. Lue HC, Tseng WP, Lin GJ, et al. Clinical and epidemiological features of rheumatic fever and rheumatic heart disease in Taiwan and the Far East. Indian Heart J. 1983;35:139-46.
37. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;3:CD002227.
38. Feinstein AR, Harrison FW, Epstein JA, et al. A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. N Engl J Med. 1959;260:697-702.
39. Wood HF, Feinstein AR, Taranta A, et al. Rheumatic fever in children and adolescents. A long term epidemiological study of subsequent prophylaxis, streptococcal infections and clinical sequelae. III. Comparative effectiveness of three prophylaxis regimes in preventing streptococcal infections and rheumatic recurrences. Ann Intern Med. 1964;60(Suppl. 5):31-46.
40. Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: A statement for health professionals. Committee on rheumatic fever, endocarditis, and Kawasaki disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995;96:758-64.
41. Rheumatic Fever Working Party. Circular Letter to Medical Practitioners, New Zealand Department of Health (HP 2/87). Rheumatic Fever Secondary Prophylaxis; 1997.
42. World Health Organization. Report of a WHO Expert Consultation on Rheumatic Fever and Rheumatic Heart Disease 29 October-1 November 2001. Geneva: World Health Organization; 2001.